Absci Corp (ABSI): Shareholders' Equity
$189.45M
As of 2025-12-31
$246.13M
As of 2026-06-30
-11.6%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $189.45M | +5.8% | 2026-03-24, Balance as of period end |
| 2024-12-31 | $179.13M | +1.7% | 2026-03-24, Balance as of period end |
| 2023-12-31 | $176.18M | -35.8% | 2025-03-18, Balance as of period end |
| 2022-12-31 | $274.41M | -25.0% | 2024-03-21, Balance as of period end |
| 2021-12-31 | $366.11M | n/m | 2023-03-30, Balance as of period end |
| 2020-12-31 | -$89.43M | n/a | 2022-03-22, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Absci Corp (ABSI) | 2025-12-31 | $189.45M | +5.8% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | $3.09M | -6.7% |
| OneMedNet Corp (ONMD) | 2025-12-31 | -$2.96M | n/m |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $7.28M | +179.7% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $11.14M | +109.3% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $267.03M | -7.2% |
| Cannabis Bioscience International Holdings, Inc. (CBIH) | 2025-05-31 | -$1.16M | n/m |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $171.49M | -16.9% |
| NRC Health (NRC) | 2025-12-31 | $13.99M | -55.3% |
Compare ABSI, ISPC, ONMD, BIAF side by side · Screen every company in Services-Commercial Physical & Biological Research ↗